MedPath

NITISINONE TABLETS

NITISINONE TABLETS

Approved
DIN Number

02458624

Drug Class

Human

Market Date

Jan 13, 2017

Company
HC

Cycle Pharmaceuticals Ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02458624
AIG Number0158450002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A16AX04 NITISINONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NITISINONEActive
Strength: 5 MG
Monograph: NITISINONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.